May 9, 2018 / 8:21 PM / 17 days ago

BRIEF-Menlo Therapeutics Reports Qtrly Loss Per Share $0.72

1 分钟阅读

May 9 (Reuters) - Menlo Therapeutics Inc:

* MENLO THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

* QTRLY LOSS PER SHARE $0.72

* LOWERING ITS OPERATING EXPENSE GUIDANCE FOR FULL YEAR 2018 TO A RANGE OF APPROXIMATELY $68.0 MILLION TO $78.0 MILLION Source text for Eikon: Further company coverage:

我们的标准：汤森路透“信任原则”

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below